Date published: 2026-4-24

1-800-457-3801

SCBT Portrait Logo
Seach Input

Sudoxicam (CAS 34042-85-8)

0.0(0)
Write a reviewAsk a question

See product citations (1)

Alternate Names:
4-Hydroxy-2-methyl-N-2-thiazolyl-2H-1,2-benzothiazine-3-carboxamide 1,1-Dioxide; N-(2-Thiazolyl)-4-hydroxy-2-methyl-2H-1,2-benzothiazine-3-carboxamide 1,1-Dioxide
Application:
Sudoxicam is a nonsteroidal, anti-inflammatory drug
CAS Number:
34042-85-8
Molecular Weight:
337.37
Molecular Formula:
C13H11N3O4S2
Supplemental Information:
This is classified as a Dangerous Good for transport and may be subject to additional shipping charges.
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.
* Refer to Certificate of Analysis for lot specific data.

QUICK LINKS

Sudoxicam that belongs to the oxicam class of compounds. It inhibits the cyclooxygenase (COX) enzymes, which are key in the biosynthesis of prostaglandins The oxicam class is characterized by a specific chemical structure that confers its ability to inhibit COX enzymes, thereby reducing the production of prostaglandins. Sudoxicam is not naturally produced within the body but is introduced externally, being detected in individuals who have been exposed to the compound or its related substances. As such, Sudoxicam is considered a component of the human exposome, which encompasses all exposures an individual encounters throughout their life.


Sudoxicam (CAS 34042-85-8) References

  1. Metabolism of sudoxicam by the rat, dog, and monkey.  |  Hobbs, DC. and Twomey, TM. 1977. Drug Metab Dispos. 5: 75-81. PMID: 13979
  2. In vitro metabolism and covalent binding of enol-carboxamide derivatives and anti-inflammatory agents sudoxicam and meloxicam: insights into the hepatotoxicity of sudoxicam.  |  Obach, RS., et al. 2008. Chem Res Toxicol. 21: 1890-9. PMID: 18707140
  3. Idiosyncratic reactions and metabolism of sulfur-containing drugs.  |  Zuniga, FI., et al. 2012. Expert Opin Drug Metab Toxicol. 8: 467-85. PMID: 22394356
  4. Dual mechanisms suppress meloxicam bioactivation relative to sudoxicam.  |  Barnette, DA., et al. 2020. Toxicology. 440: 152478. PMID: 32437779
  5. Meloxicam methyl group determines enzyme specificity for thiazole bioactivation compared to sudoxicam.  |  Barnette, DA., et al. 2021. Toxicol Lett. 338: 10-20. PMID: 33253783
  6. Ultrasensitive and simultaneous detection of 6 nonsteroidal anti-inflammatory drugs by colloidal gold strip sensor.  |  Lin, L., et al. 2021. J Dairy Sci. 104: 2529-2538. PMID: 33455779
  7. Improvement of the gastric tolerance of non-steroidal anti-inflammatory drugs by polyene phosphatidylcholine (Phospholipon 100).  |  Leyck, S., et al. 1985. Eur J Pharmacol. 117: 35-42. PMID: 4085544
  8. Anti-inflammatory and pharmacokinetic properties of sudoxicam N-(2-thiazolyl)-4-hydroxy-2-methyl-2H-1,2-benzothiazine-3-carboxamide 1,1-dioxide.  |  Wiseman, EH. and Chiaini, J. 1972. Biochem Pharmacol. 21: 2323-34. PMID: 4630489
  9. Inhibition of platelet aggregation and of experimental thrombosis by sudoxicam.  |  Constantine, JW. and Purcell, IM. 1973. J Pharmacol Exp Ther. 187: 653-65. PMID: 4770405
  10. Interaction of sudoxicam and aspirin in animals and man.  |  Wiseman, EH., et al. 1975. Clin Pharmacol Ther. 18: 441-8. PMID: 809225
  11. Anti-inflammatory drugs and renal papillary necrosis.  |  Wiseman, EH. and Reinert, H. 1975. Agents Actions. 5: 322-5. PMID: 813505
  12. Pharmacokinetics of oxicam nonsteroidal anti-inflammatory agents.  |  Olkkola, KT., et al. 1994. Clin Pharmacokinet. 26: 107-20. PMID: 8162655
  13. Clinical pharmacology of oxicams: new insights into the mechanisms of their dose-dependent toxicity.  |  Albengres, E., et al. 1993. Int J Tissue React. 15: 125-34. PMID: 8188448

Ordering Information

Product NameCatalog #UNITPriceQtyFAVORITES

Sudoxicam, 100 mg

sc-212968
100 mg
$400.00